High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia.
Marengo M, Migliori M, Merlotti G, Naso E, Dellepiane S, Medica D, Cappellano G, Cortazzi S, Colombatto A, Quercia AD, Sacco C, Leonardi G, Randone O, Maffei S, Mancini E, Borzumati M, Fabbrini P, Vidali M, Grossini E, Medana C, Bello FD, Quaglia M, Panichi V, Cantaluppi V.
Marengo M, et al. Among authors: medana c.
Nephrol Dial Transplant. 2025 Oct 30;40(11):2131-2142. doi: 10.1093/ndt/gfaf101.
Nephrol Dial Transplant. 2025.
PMID: 40478750
Free PMC article.
Clinical Trial.